TECX — Tectonic Therapeutic Share News
0.000.00%
Last trade - 00:00- $412.30m
- $185.41m
Tectonic Therapeutic Q2 net loss widens on higher costs
Tectonic Therapeutic Inc expected to post a loss of $1.35 a share - Earnings Preview
Brief: Tectonic Therapeutic Completes Enrollment In Tx45 Apex Phase 2 Clinical Trial In Ph-Hfpef Patients
Tectonic Therapeutic Q1 net loss widens on higher R&D costs
Brief: Tectonic Therapeutic Appoints Jessica Chutter To Board Of Directors
Brief: Tectonic Therapeutic Appoints François Nader As Chair And Independent Director Of The Board
U.S. STOCKS ON THE MOVE-Target, Warner Bros Discovery , Copper miners
U.S. STOCKS ON THE MOVE-Zimmer Biomet, Datadog, Ecolab
U.S. STOCKS ON THE MOVE-Vistra Corp, Quest Diagnostics, Jacobs Solutions
U.S. STOCKS ON THE MOVE-Spotify, DuPont, Hasbro
Tectonic shares plunge as AstraZeneca scraps rival relaxin drug
Tectonic Therapeutic Inc reports results for the quarter ended June 30 - Earnings Summary
Tectonic Therapeutic Inc expected to post a loss of $1.03 a share - Earnings Preview
Brief: Tectonic Therapeutic Inc Files For Offering Of Up To 3.68 Million Common Shares By Selling Stockholders - SEC Filing
Tectonic Therapeutic Inc reports results for the quarter ended March 31 - Earnings Summary
Tectonic Therapeutic Inc expected to post a loss of $1.09 a share - Earnings Preview
Brief: Tectonic Therapeutic To Present Phase 1B Data For Tx45 At European Society Of Cardiology Heart Failure 2025
Brief: Tectonic Therapeutic Announces Fourth Quarter And Full Year 2024 Financial Results And Recent Business Highlights
Tectonic Therapeutic Inc reports results for the quarter ended December 31 - Earnings Summary